Periprocedural GLP-1 use consensus - clinical guide
ANZCA, along with peak diabetes, obesity and gastroenterological bodies, has produced clinical practice recommendations for patients using GLP-1/GIP receptor agonists.
CP25(G) Policy on endorsement of externally developed guidelines
CP25(G) Policy on endorsement of externally developed guidelines
ANZCA CTN guidelines for endorsement
CTN guidelines for endorsement
FPM Practice Assessment Pathway Assessment checklist
Use this checklist for endorsement criteria to become endorsed in pain medicine procedures via the practice assessment pathway
2023 ANZCA ASM Prize session abstract examples
2023 ANZCA ASM Prize session abstract examples